Réactifs et instruments pour l'immunologie,
la biologie cellulaire et la biologie moléculaire.
Se connecter
Mot de passe oublié ?
Ouvrir un compte
0
0
Voir le panier
Catalogue
Thématiques
Diagnostic
Services à façon
Services CRO
Ressources techniques
Promotions
Contact
Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
Résultat de votre recherche : 9 produit(s) trouvé(s)
Affinez votre recherche :
RUO
CE / IVD
Conjugate (1)
Unconjugated
8
Reactivity species (1)
human
2
Class (3)
Inhibitor/Antagonist/Agonist
6
Primary antibody
2
Service
1
Host species (1)
mouse
2
Application (3)
IF
2
IHC
2
WB
2
Clone (1)
MGMT/4791
2
APPLIQUER LES FILTRES
RéINITIALISER
PARTAGER LA RECHERCHE
COPIé
10
20
50
100
200
500
Référence
Description
Cond.
Prix HT
orb1409985-20ug
MGMT (Marker of Suppressor of Mutation and Carcinogenesis) antibody
20ug
orb1409985-100ug
MGMT (Marker of Suppressor of Mutation and Carcinogenesis) antibody
100ug
orb1910729-250mg
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
250mg
orb1910729-1g
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
1g
orb1910729-100mg
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
100mg
orb1910825-1g
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
1g
orb1910825-100mg
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
100mg
orb1910825-250mg
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
250mg
ASC-6012A
CRISPR Custom cell line gene modification; point mutation, samll deletion (<200bp) (normal karyotyping, homozygous); Timeline: 3-5 months
1service
‹
›
